Dermata Therapeutics, Inc. (DRMA) Net income 2020–2025
Dermata Therapeutics, Inc. (DRMA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$7.6MFY2025 · since FY2020: -$3.2M → -$7.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.6M | +38.5% |
| FY2024 | -$12.3M | -57.6% |
| FY2023 | -$7.8M | +18.9% |
| FY2022 | -$9.6M | -21.6% |
| FY2021 | -$7.9M | -144.2% |
| FY2020 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DRMA financial trends
DRMA RevenueDRMA Net marginDRMA Gross profitDRMA Gross marginDRMA Operating incomeDRMA Operating marginDRMA Operating cash flowDRMA Free cash flowDRMA Capital expendituresDRMA Return on equityDRMA Stock buybacksDRMA Dividends paidDRMA Total assetsDRMA Total liabilitiesDRMA Shareholders’ equityDRMA overview →